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Progress in Medical Virology Vol. 28. Ed.
J. L. MELNICK (1982). Paris, London, New
York, Sydney: S. Karger. $88.75 net.
Most virologists are familiar with the series
of collected review articles which appear
annually under the title Progress in Medical
Virology and have learned to appreciate that
within these volumes Dr Melnick makes a
habit of providing a valuable overview of
current areas of interest.
Dr Melnick has done it again. This volume,
the latest in the series, comprises nine articles
which range in subject from Korean haemor-
rhagic fever through slow and latent virus
infections to a review of the taxonomy and
nomenclature of viruses as seen in 1982. The
contents indicate the current trend away from
the study ofacute virus diseases and towards,
in one direction, the chronic diseases and, in
another, the wider aspects ofvirus diseases in
the community. This latter point of view is
exemplified by an article by Koplan and
Axnick on the "Benefits, Risks and Costs of
Viral Vaccines". Benefit-risk, benefit-cost
and cost-effectiveness analysis are used to
study mumps, influenza, rubella, measles,
poliovirus and smallpox vaccines. As the
authors indicate, such analyses are useful in
determining the strategies for the community
to use in its vaccination programmes and they
hope that they will be applied to the newr
hepatitis vaccines. There is a general article
on persistent, slow and latent virus infections
and specific articles on cytomegalovirus
infections in transplant patients, the similar-
ities and differences between measles and
SSPE viruses and, at the cellular level, a
study of transformation by herpes simplex
virus. Drs Vonka and Hirsch review current
knowledge concerning the Epstein-Barr virus
nuclear antigen. Professor Trexler and Dr van
der Groen look at containment laboratories
for dangerous pathogens and describe an
inexpensive system which employs a negative
pressure flexible wall isolator in which the
operator is protected by an appropriate
plastic suit. The volume is completed by a
study of the taxonomy and nomenclature of
viruses, reflecting the important develop-
rnents which have recently taken place in this
subject.
We thus have a set of very useful
summaries of current important topics,
couched in terms which should be under-
standable to others beside professional virol-
ogists. The range of subjects treated is such
that a wide audience will potentially be
interested and it is likely that the library
copies will be well patronized. As is the case
with many other contemporary volumes,
although it can be recommended to those
individuals who are likely to be interested, the
cost may be inhibiting. The production is
excellent.
R. N. P. SUTTON
Lymphomas 1-Including Hodgkin's
Disease. By JOHN M. BENNETT (1981).
Netherlands: Martinus Nijhoff. 450 pp.
£69.50 net.
This book is part of the series on cancer
treatment and research which so far has
produced several interesting volumes of
contemporary controversy. It attempts to
review the pathology, clinical presentation
and treatment of all lymphomas; both
Hodgkin's disease and the non-Hodgkin
lymphomas. It may best be described as a
valiant effort at this very complicated topic.
In one sense the authors have problems, since
they are obliged to cover two diseases;
Hodgkin's disease and non-Hodgkin's lym-
phoma, which although both are malignancies
of the lymph nodes, behave very differently
and indeed have very different pathology. As
a result the individual chapters, although
quite long, do not deal as exhaustively as one
might wish with the individual diseases.
There are many excellent features of this
book, the discussion of the pathology of non-
Hodgkin's lymphoma is clearly written and
demonstrates the various classifications that
exist and the differences and similarities
between them. The chapter by Stein on the
clinical features and evaluation of Hodgkin's
disease and non-Hodgkin's lymphoma is
excellent. There is perhaps over-emphasis on
the anatomic substages ofStage III Hodgkin's
disease which was developed at the Centre
from which this book derives, and is not
universally accepted. Apart from this one